IP Library Granted Patent US 9,650,436
Granted Patent B2
US 9,650,436 · App. 14/434,742 · Granted May 16, 2017

Antibody based reagents that specifically recognize toxic oligomeric forms of tau

Inventors: Michael Sierks (Ft. McDowell, AZ); Huilai Tian (Tempe, AZ)
Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
C07K16/18C07K16/005C12N15/1037G01N33/6896A61K2039/505C07K2317/21C07K2317/30C07K2317/62C07K2317/622C07K2317/76G01N2333/4703G01N2800/28G01N2800/2814G01N2800/2821
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,650,436
App. No.
14/434,742
Granted
May 16, 2017
Kind
B2
Abstract

The invention relates to antibodies, antibody fragments and binding agents that specifically recognize oligomeric tau but do not bind to monomelic tau, fibrillar tau or non-disease associated forms of tau.

Claims (4)

1. A binding molecule comprising at least 80% sequence identity to amino acid sequence SEQ ID NO:1.

2. A binding molecule comprising amino acid sequence SEQ ID NO:1, SEQ ID NO:9, SEQ ID NO:11, SEQ ID NO:13, SEQ ID NO:15, SEQ ID NO:17, or SEQ ID NO:19.

3. The binding molecule of claim 2 , wherein the binding molecule comprises amino acid sequence SEQ ID NO:1, SEQ ID NO:9 or SEQ ID NO:11.

4. The binding molecule of claim 2 , wherein the binding molecule binds to oligomeric tau and does not bind monomeric tau, fibrillar tau or non-disease associated forms of tau.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 16, 2017
From: SIERKS, MICHAEL; TIAN, HUILAI
To: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
Reel/Frame 041598/0691 →
Continuity (2)
Provisional Application 61713441 · Oct 12, 2012
Related Publication 20150266947A1 · Sep 24, 2015